{"nct_id":"NCT03454451","title":"CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2018-04-25","start_date_type":"ACTUAL","primary_completion_date":"2022-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRVS"]}